The Role of the Wnt/β-Catenin Signaling Pathway in the Pathogenesis and Treatment of Spinal Cord Injury: A Review of the Latest Experimental Data
Fellouri G., Savvas K., Tsoutsi N., Kourtis E., Fanourgiakis I., Lepetsos P.
Narrative Review on Spinal Cord Injury, Scar, published in Cureus (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Cureus (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 40799869
- PMCID
- PMC12341850
- DOI
- 10.7759/cureus.87836
- Citations
- 2
Abstract (original English)
Spinal cord injury (SCI) is a debilitating condition with a high incidence, leading to irreversible motor, sensory, and autonomic dysfunctions. Despite significant advances in understanding the pathophysiology of SCI, effective therapeutic strategies for regeneration remain elusive. The Wnt/β-catenin signaling pathway has emerged as a key player in various developmental and pathological processes, including tissue regeneration, neuroprotection, and inflammation, all of which are crucial in SCI. The aim of this paper is to review the current understanding of the Wnt/β-catenin signaling pathway in the pathogenesis of SCI and its potential as a therapeutic target for improving recovery after SCI. The Wnt/β-catenin signaling pathway has a distinctive role in SCI pathogenesis, encompassing regulation of inflammation, apoptosis, glial scar, axonal repair and regeneration, and angiogenesis. Many treatment modalities, such as pharmaceutical administration, stem cell transplantation, gene therapy, electric stimulation, and the use of biomaterials and exosomes, exert beneficial effects in SCI animal models by interacting with the Wnt/β-catenin signaling pathway. The Wnt/β-catenin signaling pathway plays a multifaceted role in the pathogenesis of SCI and offers a promising avenue for therapeutic intervention. Its effects depend on the specific Wnt ligands involved, the injury stage, and t
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Host immune determinants of stromal vascular fraction graft survival: Toward a concept of SVF therapy resistance - A systematic narrative review.
Systematic Review on Spinal Cord Injury, Chronic Inflammation, Immune Modulation, published in Cell Transplant (2026) — summary generated from the PubMed abstract.
- 2026
Cell Transplant - Level AMeta-analysisPubMed
Stem cell-derived exosome treatment for acute spinal cord injury: a systematic review and meta-analysis based on preclinical evidence.
Meta-analysis on Spinal Cord Injury, published in Front Neurol (2025) — summary generated from the PubMed abstract.
- 2025
Front Neurol - Level ASystematic ReviewPubMed
Brain-derived neurotrophic factor (BDNF) as biomarker in stem cell-based therapies of preclinical spinal cord injury models: A systematic review.
Systematic Review on Spinal Cord Injury, published in Tissue Cell (2025) — summary generated from the PubMed abstract.
- 2025
Tissue Cell3 citations - Level ASystematic ReviewEurope PMC
Revolutionizing neural regeneration with smart responsive materials: Current insights and future prospects
Systematic Review on Spinal Cord Injury, published in Bioact Mater (2025) — summary generated from the PubMed abstract.
- 2025
Bioact Mater5 citations - Level ASystematic ReviewEurope PMC
Conductive Nanocomposite Hydrogels for Neural Tissue Engineering: A Systematic Scoping Review of Recent Trends
Systematic Review with a reported sample of 42 on Diabetic Foot, Stroke Research, Spinal Cord Injury, Neuroinflammation, published in Adv Sci (Weinh) (2025) — summary generated from the PubMed abstract.
- 2025
- n = 42
Adv Sci (Weinh)18 citations - Level ASystematic ReviewEurope PMC
Emerging regenerative strategies for spinal cord injury: exosome-derived mechanisms and therapeutic insights
Systematic Review on Spinal Cord Injury, Neuroinflammation, published in Front Neurosci (2025) — summary generated from the PubMed abstract.
- 2025
Front Neurosci